ASCO 2023: eNSCLCLatest
May 25, 2023
Recurrent cases of non-small cell lung cancer (NSCLC) following surgery are common and carry significant morbidity and mortality risks. A recent study assessed the effect of administering adjuvant ate....
May 22, 2023

May 22, 2023

More Meeting Coverage
ASCO 2023: HCCLatest

Jun 08, 2023
Adjuvant therapy with atezolizumab and bevacizumab improved recurrence-free survival in patients with hepatocellular carcinoma (HCC) following surgical resection or ablation, according to results from....
Jun 01, 2023

Jun 01, 2023

Jun 01, 2023

CMSC 2023: MS
AAN 2023: MSLatest
AACR 2023: eNSCLCLatest

May 19, 2023
Orphan non-coding RNAs demonstrated efficacy for accurate, sensitive, and early detection of NSCLC. “Orphan non-coding RNAs (oncRNAs) are a novel category of small non-coding RNAs that are pr....
CROI 2023Latest
Apr 25, 2023

ASCO GI 2023Latest
Mar 23, 2023

Feb 02, 2023

Jan 27, 2023

Jan 27, 2023

Jan 27, 2023

ASH 2022: LymphomaLatest
Dec 06, 2022
ASH 2022: LeukemiaLatest
Jan 23, 2023

ACR 2022Latest
Dec 21, 2022
The ACR 2022 PhysQuiz was created by the editorial staff at Physician’s Weekly. ....
Dec 21, 2022

Dec 05, 2022

Dec 02, 2022
AHA 2022Latest
Dec 14, 2022

Kidney Week 2022Latest
Dec 16, 2022
The ASN 2022 PhysQuiz was created by the editorial staff at Physician’s Weekly. ....
Dec 13, 2022

Oct 28, 2022
ECTRIMS 2022: NMOSDLatest
Dec 14, 2022
The ECTRIMS NMOSD 2022 PhysQuiz was created by the editorial staff at Physician’s Weekly. ....
Dec 07, 2022

Nov 04, 2022

ECTRIMS 2022: Multiple SclerosisLatest
Dec 07, 2022

Nov 08, 2022

ACG 2022Latest
Dec 09, 2022

SOHO 2022Latest
Dec 06, 2022

Oct 19, 2022

Sep 26, 2022